CG
NXTM

Clinton Group’s NxStage Medical Inc. NXTM Stock Holding History

Clinton Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-27,185
Closed -$713K – 1108
2016
Q4 		$713K Sell
27,185
-13,043
-32% -$323K 0.04% 479
2016
Q3 		$1M Buy
40,228
+1,114
+3% +$26K 0.05% 485
2016
Q2 		$848K Buy
39,114
+7,526
+24% +$134K 0.04% 534
2016
Q1 		$474K Buy
31,588
+12,375
+64% +$207K 0.03% 633
2015
Q4 		$421K Sell
19,213
-2,244
-10% -$41.8K 0.03% 547
2015
Q3 		$338K Buy
+21,457
New +$344K 0.03% 527

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Clinton Group's NXTM Position: Q1 2017 in Review

Clinton Group sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 27,185 shares — an estimated $713K sold.

Clinton Group first reported a position in NXTM in Q3 2015 and held it in 6 quarters. The position peaked at $1M in Q3 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Clinton Group reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Clinton Group sold 27,185 NxStage Medical Inc. shares in Q1 2017, an estimated $713K.
  • Clinton Group first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 6 quarters.
  • Clinton Group's NxStage Medical Inc. position peaked at $1M in Q3 2016.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Clinton Group's 13F filing for Q1 2017, filed 10 May 2017.